Stati Uniti - Ingliż - NLM (National Library of Medicine)

redpharm drug - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. gastrointestinal diseases to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. hematologic disorders acquired (autoimmune) hemolytic anemia, con

Stati Uniti - Ingliż - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (diamond-blackfan anemia), idiopathic thrombocytopenic purpura in a

Stati Uniti - Ingliż - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment: atopic dermatitis, bronchial asthma, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis, and serum sickness. collagen diseases during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus, and acute rheumatic carditis. dermatologic diseases bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome), severe psoriasis, and severe seborrheic dermatitis. edematous states to induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus. endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; i

Stati Uniti - Ingliż - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (diamond-blackfan anemia), idiopathic thrombocytopenic purpura in a

Stati Uniti - Ingliż - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (diamond-blackfan anemia), idiopathic thrombocytopenic purpura in a

Stati Uniti - Ingliż - NLM (National Library of Medicine)

fresenius kabi usa, llc - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. intravenous or intramuscular administration.   when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. endocrine disorders.   primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids      where applicable; in infancy, mineralocorticoid supplementation is of particular importance).      acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice;      mineralocorticoid supplementation may be necessary, particularly when synthetic       analogs are used).      preoperatively, and in the event of serious trauma or illness, in patients with known adrenal       insufficiency or when adrenocortical reserve is doubtful.      shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected.      congenital adrenal hyperplasia.      nonsuppurative thyroiditis.      hypercalcemia associated with cancer. 2. rheumatic disorders.  as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:      post-traumatic osteoarthritis.      synovitis of osteoarthritis.      rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require      low-dose maintenance therapy).      acute and subacute bursitis.      epicondylitis.      acute nonspecific tenosynovitis.      acute gouty arthritis.      psoriatic arthritis.      ankylosing spondylitis. 3.   collagen diseases. during an exacerbation or as maintenance therapy in selected cases of:      systemic lupus erythematosus.      acute rheumatic carditis. 4.   dermatologic diseases.      pemphigus.      severe erythema multiforme (stevens-johnson syndrome).      exfoliative dermatitis.      bullous dermatitis herpetiformis.      severe seborrheic dermatitis.      severe psoriasis.      mycosis fungoides. 5. allergic states.   control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in:      bronchial asthma.      contact dermatitis.      atopic dermatitis.      serum sickness.      seasonal or perennial allergic rhinitis.      drug hypersensitivity reactions.      urticarial transfusion reactions.      acute noninfectious laryngeal edema (epinephrine is the drug of first choice). 6. ophthalmic diseases.   severe acute and chronic allergic and inflammatory processes involving the eye, such as:      herpes zoster ophthalmicus.      iritis, iridocyclitis.      chorioretinitis.      diffuse posterior uveitis and choroiditis.      optic neuritis.      sympathetic ophthalmia.      anterior segment inflammation.      allergic conjunctivitis.      allergic corneal marginal ulcers.      keratitis. 7. gastrointestinal diseases.   to tide the patient over a critical period of the disease in:      ulcerative colitis (systemic therapy).      regional enteritis (systemic therapy). 8. respiratory diseases.      symptomatic sarcoidosis.      berylliosis.      fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate       anti-tuberculosis chemotherapy.      loeffler’s syndrome not manageable by other means.      aspiration pneumonitis. 9. hematologic disorders.      acquired (autoimmune) hemolytic anemia.      idiopathic thrombocytopenic purpura in adults      (i.v. only; i.m. administration is contraindicated).      secondary thrombocytopenia in adults.      erythroblastopenia (rbc anemia).      congenital (erythroid) hypoplastic anemia. 10. neoplastic diseases.   for palliative management of:      leukemias and lymphomas in adults.      acute leukemia of childhood. 11. edematous states.   to induce diuresis or remission of proteinuria in the nephrotic syndrome,         without uremia, of the idiopathic type or that due to lupus erythematosus. 12.   nervous system.          acute exacerbations of multiple sclerosis. 13. miscellaneous.      tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate anti-tuberculosis chemotherapy.      trichinosis with neurologic or myocardial involvement.      diagnostic testing of adrenocortical hyperfunction.       cerebral edema of diverse etiologies in conjunction with adequate neurological evaluation and management. b. intra-articular or soft tissue administration.   when the strength and dosage form of the drug lend      the preparation to the treatment of the condition, those products labeled for intra-articular or soft      tissue administration are indicated as adjunctive therapy for short-term administration     (to tide the patient over an acute episode or exacerbation) in:      synovitis of osteoarthritis.      rheumatoid arthritis.      acute and subacute bursitis.      acute gouty arthritis.      epicondylitis.      acute nonspecific tenosynovitis.      post-traumatic osteoarthritis. c. intralesional administration. when the strength and dosage form of the drug lend the preparation to       the treatment of the condition, those products labeled for intralesional administration are       indicated for:      keloids.      localized hypertrophic, infiltrated, inflammatory lesions of: lichen planus,      psoriatic plaques, granuloma annulare, and lichen simplex chronicus      (neurodermatitis).      discoid lupus erythematosus.      necrobiosis lipoidica diabeticorum.      alopecia areata.      they also may be useful in cystic tumors of an aponeurosis tendon (ganglia). systemic fungal infection.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

fresenius kabi usa, llc - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: - endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected. congenital adrenal hyperplas

Stati Uniti - Ingliż - NLM (National Library of Medicine)

remedyrepack inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (diamond-blackfan anemia), idiopathic thrombocytopenic purpura in adults, pure red cell aplasia, and selected cases of secondary thrombocytopenia. diagnostic testing of adrenocortical hyperfunction, trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy. for the palliative management of leukemias and lymphomas. acute exacerbations of multiple sclerosis, cerebral edema associated with primary or metastatic brain tumor, craniotomy, or head injury. sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids. to induce a diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). for the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus. systemic fungal infections (see warnings: fungal infections) and in patients who are hypersensitive to any components of these products.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

golden state medical supply, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (diamond-blackfan anemia), idiopathic thrombocytopenic purpura in a

Stati Uniti - Ingliż - NLM (National Library of Medicine)

remedyrepack inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (diamond-blackfan anemia), idiopathic thrombocytopenic purpura in a